There were 1,964 press releases posted in the last 24 hours and 440,360 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image